40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Analyze DCF forecasts for the company and compare them with competitors.
6.73B
No previous data to compare.
No Data
No DCF data available for this metric in the selected year.
2.75B
No previous data to compare.
40.87%
No previous data to compare.
697.00M
No previous data to compare.
10.36%
No previous data to compare.
2.05B
No previous data to compare.
190.00M
No previous data to compare.
2.82%
No previous data to compare.
1.15B
No previous data to compare.
17.04%
No previous data to compare.
7.00M
No previous data to compare.
0.10%
No previous data to compare.
348.00M
No previous data to compare.
5.17%
No previous data to compare.
-2.63B
No previous data to compare.
-39.04%
No previous data to compare.
11.70%
No previous data to compare.
16.87%
No previous data to compare.
5.31%
No previous data to compare.
2.64
No previous data to compare.
263.90M
No previous data to compare.
6.68B
No previous data to compare.
10.03B
No previous data to compare.
16.71B
No previous data to compare.
39.98%
No previous data to compare.
60.02%
No previous data to compare.
517.77M
No previous data to compare.
-861.23M
No previous data to compare.
0.50%
No previous data to compare.
-12.22B
No previous data to compare.
-11.02B
No previous data to compare.
6.68B
No previous data to compare.
-17.70B
No previous data to compare.
-67.06
No previous data to compare.
Analyze analyst forecasts for the company and compare them with competitors.
5.41B
The estimated revenue has decreased from the previous period.
558.96M
The estimated EBITDA has increased from the previous period.
2.40
The estimated EPS has increased from the previous period.
326.46M
The estimated net income has increased from the previous period.
864.80M
The estimated EBIT has increased from the previous period.
347.17M
The estimated SG&A expenses have decreased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Analysts expect the stock price to increase by 27.11%.
Buy
Positive consensus among analysts.
